Key clinical point: The psoriatic arthritis (PsA) disease burden had worse impact on women vs men with PsA, with women having a higher disease activity, worse function, and greater disease burden.
Major finding: Female vs male patients with PsA had a significantly higher mean patient global assessment score ( P < .001), patient’s pain score ( P = .003 ), tender joint count ( P < .001), swollen joint count ( P = .033), and Disease Activity Score for PsA ( P < .001). Minimal disease activity was achieved by 44.0% of men vs 24.6% of women ( P = .003).
Study details: Findings are from a cross-sectional analysis of 2 longitudinal cohorts including 141 male and 131 female patients with PsA who received treatment with conventional synthetic or biologic disease-modifying antirheumatic drugs for at least 6 months.
Disclosures: This study did not receive funding. The authors declared no conflicts of interest.
Source: Lubrano E et al. Psoriatic arthritis in males and females: Differences and similarities. Rheumatol Ther. 2023 (Feb 16). Doi: 10.1007/s40744-023-00535-3